Stocks
GlaxoSmithKline (GSK) P/BV US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| P/BV | ? | -2.04 | 0.00 | 0.00 | -7.81 | -13.5 | -10.2 | ||
| Changes by years, y/y, % | -2% | -100% | +72% | +45.4% | |||||
GlaxoSmithKline. P/BV
GlaxoSmithKline. P/BV, changes, %
GlaxoSmithKline (GSK) P/BV US GAAP (quarter values) |
||||||||
| FY2025Q3 | FY2025Q4 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| P/BV | ? | -8.25 | -13.4 | -6.68 | -11.1 | -16.2 | -10.2 | |
| Changes by years, y/y, % | -24% | +71% | -15% | +64% | +108% | |||
| Changes by quarters, q/q, % | +6% | +62% | -50% | +66% | +46% | |||
